Cultural stigmas against treatment may be reduced by providing information about mental health in a second language.

Published Date: 26 Apr 2023

By using interpretation and translation to present information to communities in their native language, public health outreach initiatives frequently aim to break down communication barriers. However, bilingual people from various cultural backgrounds.

Read Full News

Latest News

Sunscreen Myths: How Evidence Morphed Into Skepticism

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

How to Mange Benign Prostatic Hypertrophy in Primary Care

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

For Everyday Shoulder Pain, Less Treatment Is Often More

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

Regular Physical Exercise Tied to Lower Mental Disorder Risk

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Hormonal Contraception Not Linked to Flare Risk in UC

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

Are Pediatricians Following Newborn Jaundice Guidelines?

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

News All Time

Menopausal Hormone Therapy May Cut Costs, Improve Health

An analysis finds that menopausal hormone therapy could save thousands of dollars per patient while improving quality of life and reducing cardiovascular disease and deaths.

Real-Life Walking Speed Can Track MS Progression

Wearable accelerometer-based real-life walking speed monitoring can track disability progression earlier and more often than conventional tests in primary progressive multiple sclerosis.

Autism Prevalence Rising Among School-Aged Kids in England

The prevalence of autism continues to rise among school-aged children and young people in England, an analysis of data from 2016 to 2024 shows.

Cannabis Use Linked to Earlier Psychosis Onset

Cannabis users experience psychosis onset 2.5 years earlier on average compared with non-users, a meta-analysis shows.

Radiation in Pancreatic Cancer: ASTRO Updates Its Guidance

The new guidance strengthens radiation therapy recommendations in pancreatic cancer, providing an update to the 2019 guidance.

How Primary Care Physicians Can Support Addiction Recovery

Rural clinicians provide addiction care despite limited services, long travel distances, and gaps in treatment access that can make ongoing support difficult for patients.

Vaccines Saved Millions: The Success That Became Invisible

Declining vaccination coverage and rapidly spreading misinformation contribute to renewed outbreaks of diseases once controlled through widespread immunization.

Physical Activity and Dementia: A Work-Leisure Divide

Staying active during leisure time is linked to a lower risk for dementia, whereas physical activity on the job showed the opposite pattern.

County-Level Medical Debt Tied to Poorer Cancer Survival

Americans living in areas mired in medical debt have later cancer diagnoses and lower survival rates.

The Study-Backed Anxiety Risk Doctors Rarely Recognize

Decades of research show that joint hypermobility, which affects 10%-15% of the population, increases the risk for anxiety and other mental health issues — yet the link remains largely unacknowledged.

Shingles in Young Australians Prompts Vaccination Discussion

The increasing number of younger patients with shingles has prompted debate about expanding free vaccination eligibility.

Fostemsavir Shows Promise in Multidrug-Resistant HIV

Fostemsavir is associated with maintained viral suppression in many heavily treated patients with multidrug-resistant HIV.

Oseltamivir May Cut ICU Admission Risk in Kids With Flu

Children hospitalized with influenza who receive oseltamivir have a lower risk for ICU admissions and shorter hospital stays than those who do not receive the treatment.

Early CF Therapy Improves Olfaction in Young Children

Young children with cystic fibrosis experience improvements in olfactory function and odor identification after 1 year of elexacaftor-tezacaftor-ivacaftor therapy.

ESC 2026: Clinical Trials That Could Change Practice

Which ESC 2026 trials matter most? An expert preview singles out the studies most likely to open new therapeutic avenues or challenge current practice.

Microbiome ‘Leak’ From Mouth to Gut Can Flag GI Cancer

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal cancers with greater accuracy than conventional stool testing.

Recommended News For You

Nuclear missile workers are contracting cancer: They blame the bases

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

New clinical recommendation for local treatment of oligometastatic lung cancer.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

Radiation therapy for patients with breast cancer

Recommended Articles For You

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Precision Risk Mapping in Cancer Prevention Programs 

The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning 

Exploring the Hope of New Treatments for Rhabdomyosarcoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New Immune Therapy Boosts Disease Control in Prostate Cancer

2.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

3.

Stem Cell Transplant Associated With Better PFS in NKTCL

4.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

5.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

1.

Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling

2.

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide

3.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

4.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

5.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Expert Perspectives on Hematology

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

Nutrition During Cancer Treatment

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot